MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Galecto P/B Ratio 2011-2025 | GLTO
Annual P/B Ratio Galecto
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.723 | 0.835 | 0.653 | 0.538 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.835 | 0.538 | 0.687 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.71 | 0.86 % | $ 782 M |  Canada |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
0.347 | $ 1.3 | - | $ 7.09 M |  China |
 |
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.25 | -3.27 % | $ 251 M |  USA |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 220.42 | - | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.29 | -3.8 % | $ 7.92 B |  Australia |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
BioVie
BIVI
|
0.128 | $ 1.45 | -3.97 % | $ 2.14 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
BioNTech SE
BNTX
|
5.29 | $ 94.81 | -1.24 % | $ 27.2 B | Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.27 | -2.43 % | $ 1.22 B | USA |
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 9.56 | 0.74 % | $ 140 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.28 | -1.77 % | $ 609 M |  Israel |
 |
Catalyst Biosciences
CBIO
|
0.428 | $ 14.09 | - | $ 928 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
17.1 | $ 564.28 | - | $ 42.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.3 | 0.88 % | $ 14.4 M | USA |
 |
AstraZeneca PLC
AZN
|
2.07 | $ 89.83 | - | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
1.26 | $ 9.0 | - | $ 1.47 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.53 | - | $ 746 M | USA |
 |
Biogen
BIIB
|
1.16 | $ 174.1 | - | $ 25.3 B | USA |
 |
Abeona Therapeutics
ABEO
|
10.1 | $ 5.36 | - | $ 115 M | USA |
 |
Cellectar Biosciences
CLRB
|
-3.23 | $ 3.62 | -4.86 % | $ 44.2 M | USA |
 |
ADiTx Therapeutics
ADTX
|
0.00714 | $ 2.24 | - | $ 29.5 K | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
0.549 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
1.97 | - | - | - | Russia |
 |
BioLineRx Ltd.
BLRX
|
19.9 | $ 3.3 | 2.17 % | $ 908 M | Israel |